Riskpilot← Back to searchSign inGet full accessDoktor Bodil AB
ABDissolvedOrg 5591145999General medical practice activities · NACE 8621Est. 20171 employees
Revenue 2023
SEK 10K
-1000100% vs 2022
EBITDA margin
58.6%
+159% vs 2022
Equity ratio
94.5%
Financial strength
Net profit 2023
SEK 6K
+157% vs 2022
| Revenue | SEK 10K | -1000100% |
| EBITDA | SEK 6K | +159% |
| Net profit | SEK 6K | +157% |
| Total assets | SEK 49K | -12% |
| Equity | SEK 46K | +14% |
| Employees | 1 | — |
Legal name
Doktor Bodil AB
Org number
5591145999
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 juni 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Uthyrning av läkare och konsultuppdrag inom hälsovård.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 54 | 62 | 84 | −0 | 10 |
| Staff expenses | — | — | — | −0 | — |
| EBITDA | 35 | 47 | 61 | −10 | 6 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 35 | 47 | 61 | −10 | 6 |
| Net financials | — | — | — | — | −0 |
| Profit before tax | 34 | 47 | 61 | −10 | 6 |
| Tax | −7 | −10 | −13 | — | — |
| Net profit | 27 | 37 | 48 | −10 | 6 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 105 | 112 | 124 | 56 | 49 |
| Equity | 78 | 88 | 100 | 41 | 46 |
| Long-term debt | 0 | 0 | 0 | 1 | 1 |
| Short-term debt | 26 | 24 | 25 | 14 | 2 |
| Total debt | 26 | 24 | 25 | 15 | 3 |
EBITDA margin
58.6%
This company
15.8%
Market median
+271% vs market
20192023
Equity ratio
94.5%
This company
38.2%
Market median
+147% vs market
20192023
Return on equity
12.3%
This company
18.4%
Market median
+33% vs market
20192023
Net profit margin
56.7%
This company
8.1%
Market median
+600% vs market
20192023
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20192023
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doktor Bodil AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birgitta Eleonora S Andersson | Deputy Board Member | 0 companies |
| Elisabet Hugosdotter Ljungström | Deputy Board Member | 0 companies |
| Anna Bodil Gessler | Board of Directors | 0 companies |
| Mats Erik Lindén | Board of Directors | 0 companies |